[Quantum Nuova Quantum Sensing] Makes Its Debut at a Prestigious Academic Conference, Supporting Innovative Mitochondrial Research | Beijing Yunshang Intelligent Manufacturing Attends the 4th Annual Meeting of the Mitochondrial Biology Section

26-04-17

[Quantum Nuova Quantum Sensing] Makes Its Debut at a Prestigious Academic Conference, Supporting Innovative Mitochondrial Research | Beijing Yunshang Intelligent Manufacturing Attends the 4th Annual Meeting of the Mitochondrial Biology Section

From April 7 to 9, 2026, the highly prestigious and authoritative premier academic forum in China’s mitochondrial research community—the Fourth Annual Meeting of the Mitochondrial Biology Division of the Chinese Biophysical Society—will be grandly held in Wuhu, Anhui Province. This year’s meeting will bring together outstanding research teams from across the country, leading experts in the field, and cutting-edge technology companies to discuss the latest advances at the forefront of mitochondrial research.

IMG_256

 

IMG_257

Beijing Yunshang Intelligent Manufacturing is making its debut at this academic annual conference by showcasing the Dutch Quantum Nuova quantum sensing and detection platform, which offers in situ, real-time, quantitative analysis of mitochondrial free-radical dynamics, oxidative stress, and dynamic metabolic changes.

During the conference, numerous scholars stopped by to seek information, and Yuan Qiyi, Deputy General Manager of Yunshang Intelligent Manufacturing, engaged in multiple in-depth exchanges with attending experts, scholars, and research teams, sharing the technology’s technical advantages and application cases. The technology was recognized by several domain experts.

IMG_258

The Quantum Nuova quantum sensing platform for mitochondrial detection targets the mitochondrion, the central hub of cellular energy metabolism and reactive oxygen species production; mitochondrial dysfunction is closely linked to cancer, neurodegenerative diseases, inflammation, and other conditions. Conventional detection methods typically rely on population-averaged, indirect measurements with limited spatiotemporal resolution, making it difficult to precisely capture localized dynamic changes in mitochondrial function.

IMG_259

How Quantum Nuova Works

IMG_260

Yunshang Intelligent Manufacturing has introduced quantum diamond relaxation technology, which employs fluorescent nanodiamonds as intracellular magnetic sensors. By monitoring changes in the nitrogen-vacancy (NV) center spin relaxation time (T1), this approach directly detects local paramagnetic free radicals within mitochondria, enabling label-free, non-invasive, live-cell, subcellular–level quantitative monitoring. With a spatial resolution of several hundred nanometers, the technique can clearly distinguish mitochondrial signals from cytoplasmic signals; it also exhibits excellent biocompatibility and strong photostability, making it suitable for a wide range of applications, including live-cell imaging, isolated-mitochondria studies, hypoxia/reoxygenation experiments, and pharmacological interventions.

IMG_261

Quantum Nuova enables real-time tracking of mitochondrial free-radical signaling.

IMG_262

Value Creation by Quantum Nuova: Free Radical Signaling and Stress Measurement During presentations at the conference, Quantum Nuova’s cutting-edge value was thoroughly showcased through exchanges with expert representatives, highlighting its technological advantages and application case studies while exploring optimization strategies such as precise targeting and quantitative calibration. This technology effectively addresses the limitations of conventional methods, providing a novel tool for research in areas such as mitochondrial oxidative stress, metabolic regulation, and drug screening.

IMG_263

Quantum Nuova’s participation in the Annual Meeting of the Mitochondrial Biology Division of the Chinese Biophysical Society and its public debut this time mark the official introduction of quantum sensing technology into China’s research community by Yunshang Intelligent Manufacturing. Moving forward, Yunshang Intelligent Manufacturing will continue to leverage its innovative Quantum Nuova platform to serve outstanding domestic research teams, thereby advancing China’s fundamental mitochondrial research and clinical translation to new heights.

✦✦✦ Quantum Nuova: Case Studies on Mitochondrial Detection ✦✦✦

IMG_264
IMG_265
IMG_266
IMG_267
IMG_268
IMG_269
IMG_270

Please contact us for project consulting and collaboration.

www.yuns3d.com

support@chinayuns.com

Beijing Headquarters

Room 708, Building 2, Phase I, HICOOL Industrial Park, Shunyi District, Beijing

400 900 5667 / 010-86399225

Previous article

Next Article

Related News


The applications of 3D printing in the medical field continue to expand.

In today’s era of rapid advances in medical technology, 3D printing, with its unique manufacturing advantages, is penetrating every facet of the healthcare sector at an unprecedented pace—ranging from the fabrication of personalized implants and the planning of complex surgical procedures to tissue engineering and drug discovery. Its applications continue to expand, ushering in a revolutionary transformation of modern medicine.


Unlocking the Full-Chain Value of 3D Printing

Amid the wave of transformation and upgrading in manufacturing, 3D printing—with its disruptive “digital-to-physical” manufacturing paradigm—is reshaping the global industrial landscape. From aerospace to biomedicine, from consumer electronics to construction, 3D printing has moved beyond prototype development and is now advancing toward the large-scale production of end-use parts. By 2025, the global 3D-printing market is projected to exceed US$21.9 billion, with China leading the Asia-Pacific region at a compound annual growth rate of 27%. This remarkable growth is underpinned by collaborative innovation across the entire value chain and a fundamental reconfiguration of industry value.


3D printing enables scalable mass production, reduces material usage by 50%, and promotes the widespread adoption of additive manufacturing in consumer electronics.

Amid the sweeping transformation of manufacturing toward intelligence and sustainability, 3D printing is boldly redefining the boundaries of traditional manufacturing. Spanning industries from aerospace and consumer electronics to personalized healthcare and architectural innovation, this technology—which builds objects layer by layer based on digital models—has not only achieved breakthroughs in scalable mass production but also accelerated the adoption of additive manufacturing in the consumer electronics sector through key advantages such as enhanced material utilization and streamlined process workflows.


The Era of Consumer-Grade Continuous-Fiber 3D Printing

Amid the ongoing wave of breakthroughs in 3D printing technology, consumer-grade continuous-fiber 3D printing is making a disruptive entry into the public eye. Once regarded as an industrial-only capability, this technology is now moving from the laboratory to home workstations—thanks to technological innovation and cost reductions—thereby redefining the boundaries of “personalized manufacturing.”


The field of 3D-printed pharmaceuticals holds vast potential.

Amid the pharmaceutical industry’s shift toward intelligent and personalized solutions, 3D-printed medicines are poised to disrupt traditional drug discovery and manufacturing paradigms. Spanning the journey from laboratory prototypes to clinical applications, and from personalized customization to large-scale production, this innovative technology—integrating digital tools with materials science—is steadily overcoming technical hurdles and regulatory barriers, thereby injecting new momentum into the global healthcare sector.